Do I receive a certificate after completing Inspection Close-Out, Enforcement Risk, and Long-Term FDA Relationship Management?

Yes, a certificate of completion is included with your registration.

Home/Catalog/Inspection Close-Out, Enforcement Risk, and Long-Term FDA Relationship Management

Recorded WebinarNew

Inspection Close-Out, Enforcement Risk, and Long-Term FDA Relationship Management

Manage FDA inspection close-out, Form 483 responses, CAPA commitments, and executive accountability to reduce enforcement risk and build long-term regulatory credibility.

4.8(0 reviews)

1.5 hours

Instructor

Charles H. Paul

President, CHP Consulting LLC — Regulatory Compliance & Operational Excellence

Inspection Close-Out, Enforcement Risk, and Long-Term FDA Relationship Management

Quantity

Recording – 1 Viewer

$290.00

Buy Now

Secure payment via Stripe

Certificate of completion

What You'll Learn

What FDA has already decided before the close-out meeting and how to interpret investigator tone

FDA 483 strategy — how FDA evaluates response credibility and common escalation mistakes

Avoiding over-correction and over-commitment in CAPA responses

FDA expectations for executive awareness and oversight after inspection

Building inspection memory into the QMS to prevent repeat observations

Establishing long-term FDA inspection resilience across sites and teams

About This Event

This course teaches participants how to manage inspection close-out activities, FDA communications, and post-inspection commitments in a way that reduces enforcement risk and supports long-term regulatory credibility. This session addresses what happens after inspection findings begin to take shape — focusing on inspection close-out, FDA Form 483 outcomes, and post-inspection regulatory risk management. Participants learn how to engage professionally during close-out discussions without escalating risk, and how to avoid CAPA over-commitment. Topics include management accountability after inspection, building inspection memory into the QMS, and establishing long-term FDA inspection resilience. Code: SEM37644

Curriculum

The FDA Close-Out Meeting — What Investigators Have Already Decided

12 min

FDA 483 Strategy Beyond the Response Letter

12 min

CAPA Commitments Under FDA Scrutiny — Avoiding Over-Commitment

12 min

Requirements

QA, Regulatory Affairs, Compliance, and Manufacturing managers
Applicable to site heads, CAPA owners, change control managers, and executive leadership

Meet Your Instructor

Charles H. Paul

President, CHP Consulting LLC — Regulatory Compliance & Operational Excellence

Charles H. Paul is President of CHP Consulting LLC, a regulatory compliance, operational excellence, training, and technical documentation consulting firm supporting pharmaceutical, biotechnology, medical device, and advanced therapy organizations worldwide. With more than 30 years of experience in regulated manufacturing environments, Charles specializes in helping organizations build sustainable quality systems that support compliance, operational performance, workforce effectiveness, and inspection readiness. His experience includes GMP quality systems, manufacturing operations, technical training development, process validation, deviation management, CAPA systems, operational excellence, documentation systems, and regulatory inspection preparation. Charles has supported organizations implementing new technologies, expanding manufacturing operations, establishing quality infrastructures, and preparing for complex regulatory inspections. He is a recognized author, speaker, and consultant who has delivered numerous webinars and seminars on GMP compliance, quality systems, human performance improvement, technical documentation, inspection readiness, and operational excellence throughout the life sciences industry.

30+ Years Regulatory ConsultingAdvanced Therapy GMP SpecialistSOP & Documentation ExpertLife Sciences Trainer & Author

Quantity

Recording – 1 Viewer

$290.00

Buy Now

Secure payment via Stripe

Certificate of completion

Event Details

Format

Recorded Webinar

Duration

1.5 hours

Certificate

Included

Access

Lifetime

Topics

FDA Inspection Close-Out Form 483 Enforcement CAPA Warning Letter Regulatory

Related Events

AI in GMP: What the FDA Is Already Expecting - Before You Ask

Live WebinarNew-24%

Regulatory & ComplianceCertificate

AI in GMP: What the FDA Is Already Expecting - Before You Ask

FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.